SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-022412
Filing Date
2021-04-30
Accepted
2021-04-30 13:52:36
Documents
60
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cmpx-10q_20210331.htm 10-Q 1095356
2 EX-31.1 cmpx-ex311_21.htm EX-31.1 20206
3 EX-31.2 cmpx-ex312_22.htm EX-31.2 20320
4 EX-32.1 cmpx-ex321_20.htm EX-32.1 9182
5 EX-32.2 cmpx-ex322_19.htm EX-32.2 9088
  Complete submission text file 0001564590-21-022412.txt   4256365

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cmpx-20210331.xml EX-101.INS 788203
7 XBRL TAXONOMY EXTENSION SCHEMA cmpx-20210331.xsd EX-101.SCH 38157
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cmpx-20210331_cal.xml EX-101.CAL 42770
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cmpx-20210331_def.xml EX-101.DEF 123660
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmpx-20210331_lab.xml EX-101.LAB 316463
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmpx-20210331_pre.xml EX-101.PRE 240302
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39696 | Film No.: 21876324
SIC: 2836 Biological Products, (No Diagnostic Substances)